Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 26;12(3):960.
doi: 10.3390/jcm12030960.

Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions

Andrea Kallmeyer  1   2 , Ana María Pello Lázaro  1   2 , Luis M Blanco-Colio  3   4 , Álvaro Aceña  1   2 , Óscar González-Lorenzo  1   2 , Nieves Tarín  5 , Carmen Cristóbal  6   7 , Carlos Gutiérrez-Landaluce  6 , Ana Huelmos  8 , Jairo Lumpuy-Castillo  2   9 , Marta López-Castillo  1   2 , Juan Manuel Montalvo  2 , Joaquín J Alonso Martin  7   10 , Lorenzo López-Bescós  7 , Jesús Egido  2   3   9   11 , Óscar Lorenzo  2   3   9 , José Tuñón  1   2   3   4
Affiliations

Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions

Andrea Kallmeyer et al. J Clin Med. .

Abstract

The pathophysiological mechanisms underlying Myocardial Infarction with Non-Obstructive Coronary Artery Disease (MINOCA) are still under debate. Lipoprotein (a) [Lp(a)] has proinflammatory and prothrombotic actions and has been involved in the pathogenesis of atherosclerosis. However, no previous studies have linked Lp(a) levels with the probability of developing MINOCA. Moreover, the relationship between MINOCA and the plasma levels of other proatherogenic and proinflammatory molecules such as Interleukin-18 (IL18) and proprotein convertase subtilisin/kexin type 9 (PCSK9) has not been studied. We conducted a prospective, multicenter study involving 1042 patients with acute myocardial infarction (AMI). Seventy-six patients had no significant coronary lesions. All patients underwent plasma analysis on admission. MINOCA patients were younger (57 (47-68) vs. 61 (52-72) years; p = 0.010), more frequently female (44.7% vs. 21.0%; p < 0.001), and had lower rates of diabetes and of Lp(a) > 60 mg/dL (9.2% vs. 19.8%; p = 0.037) than those with coronary lesions; moreover, High Density Lipoprotein cholesterol (HDL-c) levels were higher in MINOCA patients. The absence of Lp(a) > 60 mg/dL and of diabetes were independent predictors of MINOCA, as well as female sex, high HDL-c levels, and younger age. IL-18 and PCSK9 levels were not predictors of MINOCA. During a follow-up of 5.23 (2.89, 7.37) years, the independent predictors of the primary outcome (acute ischemic events or death) in the whole sample were Lp(a) > 60 mg/dL, older age, low estimated Glomerular Filtration rate (eGFR), hypertension, previous heart failure (HF), coronary artery bypass graft, use of insulin, and no therapy with acetylsalicylic acid. In conclusion, in AMI patients, the absence of high Lp(a) levels, as well high HDL-c levels, were independent predictors of the inexistence of coronary artery disease. High Lp (a) levels were also an independent predictor of ischemic events or death.

Keywords: MINOCA; PCSK9; acute myocardial infarction; inflammation; interleukin-18; lipoprotein(a).

PubMed Disclaimer

Conflict of interest statement

The authors have not conflict of interest.

References

    1. Ferretti G., Bacchetti T., Johnston T.P., Banach M., Pirro M., Sahebkar A. Lipoprotein(a): A missing culprit in the management of athero-thrombosis? J. Cell. Physiol. 2017;233:2966–2981. doi: 10.1002/jcp.26050. - DOI - PubMed
    1. Reyes-Soffer G., Westerterp M. Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation. Pharmacol. Res. 2021;169:105689. doi: 10.1016/j.phrs.2021.105689. - DOI - PMC - PubMed
    1. Kamstrup P.R. Lipoprotein(a) and Cardiovascular Disease. Clin. Chem. 2021;67:154–166. doi: 10.1093/clinchem/hvaa247. - DOI - PubMed
    1. Tsimikas S. A Test in Context: Lipoprotein(a) J. Am. Coll. Cardiol. 2017;69:692–711. doi: 10.1016/j.jacc.2016.11.042. - DOI - PubMed
    1. Pustjens T.F.S., Appelman Y., Damman P., Berg J.M.T., Jukema J.W., de Winter R.J., Agema W.R.P., van der Wielen M.L.J., Arslan F., Rasoul S., et al. Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): A position paper from the Dutch ACS working group. Neth. Hear. J. 2019;28:116–130. doi: 10.1007/s12471-019-01344-6. - DOI - PMC - PubMed